Company Management

Hexima Limited (ASX:HXL)

Biotechnology Research Melbourne, Victoria, Au 7 employees

Employees: 7
Contacts: 3
Emails: 3
Phones: 1

hexima.com.au LinkedIn Crunchbase

Hexima Limited (ASX:HXL) Overview

Headquarters: Melbourne, Victoria, Au
Phone Number: Available in AeroLeads
Website: hexima.com.au
Industry: Biotechnology Research
Employees: 7
Founded: 1998
Funding: 1.1M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Fungal Pathogens Antifungal peptides Onychomycosis

About Hexima Limited (ASX:HXL)

Hexima is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics. Our lead product candidate, pezadeftide (formally HXP124) applied in a topical formulation, is a potential new prescription treatment for toenail fungal infections (or onychomycosis). Hexima is currently conducting an Australian phase IIb clinical trial testing pezadeftide for the treatment of onychomycosis. Hexima holds granted, long-life patents protecting pezadeftide in major markets globally.

Hexima Limited (ASX:HXL) Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage
Phone contacts: 1; 33.3% coverage

Hexima Limited (ASX:HXL) Org Chart

Sample employees and titles

Name	Title	Location	Contact
Leanne Ralph	Non-executive Director, Company	Greater Sydney Area, Australia	Email Phone
Nicole Van Der Weerden	Chief Operating Officer at Arovella	Greater Melbourne Area, Australia	Email
Geoffrey Kempler	Board Director	Greater Melbourne Area, Australia	Email